Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence
Phase 2
Completed
- Conditions
- Biochemical Failure
- Registration Number
- NCT00579332
- Lead Sponsor
- Vanderbilt University
- Brief Summary
Pilot and feasibility diet and phyto-agent intervention among healthy men at risk for prostate cancer progression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 16
Inclusion Criteria
- Men with PSA recurrence following prostatectomy
Exclusion Criteria
- Not using exogenous hormones
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method change in blood PSA levels 6 months
- Secondary Outcome Measures
Name Time Method monitor for health events 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie I3C's anti-cancer effects in prostate cancer recurrence?
How does brassica intervention compare to standard-of-care treatments for biochemical failure post-prostatectomy?
Which biomarkers predict response to indole-3-carbinol in prostate cancer progression?
What adverse events are associated with Brassica-based dietary supplements in prostate cancer patients?
Are there combination therapies involving I3C and androgen deprivation therapy for prostate cancer recurrence?
Trial Locations
- Locations (1)
Vanderbilt_University
🇺🇸Nashville, Tennessee, United States
Vanderbilt_University🇺🇸Nashville, Tennessee, United States